Could a common allergy drug slow ALS?
Disease control
Recruiting now
This study tests whether PHENOGENE-1A (cromolyn) can help people with mild to moderate ALS when added to their usual care. About 105 participants will receive either the drug or a placebo twice daily for 24 weeks. Researchers will measure changes in muscle function, breathing, an…
Phase: PHASE2 • Sponsor: PhenoNet, Inc. • Aim: Disease control
Last updated May 26, 2026 09:33 UTC